Biogen · 1 month ago
Associate Director, Strategy & Operations - Lupus
Biogen is a mid-sized biotechnology company committed to delivering life-changing medicines. The Associate Director of Strategy & Operations for the U.S. Specialty franchise will play a critical role in aligning and coordinating operations as the company prepares for multiple lupus launches, working closely with cross-functional leaders to ensure strategic planning and execution.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Partner with the Head of Strategy & Ops to run the U.S. Lupus operating model, including standing leadership forums, launch readiness meetings, and governance reviews
Lead meeting preparation: develop agendas, synthesize updates, draft executive-ready pre-reads, and coordinate follow-ups and action tracking
Ensure clear alignment and timely execution across Commercial, Medical, Access, Commercial Operations, and Analytics
Coordinate cross-functional launch readiness deliverables, timelines, and dependencies across CLE and SLE indications
Maintain and manage trackers, GTM launch plans, and milestone dashboards
Support risks/mitigations, scenario planning, and operational issue escalation
Liaise with data/insights partners to consolidate inputs into concise narratives for leadership
Support operational budget tracking and coordination of Lupus-related investment planning
Track deliverables, performance indicators, and operational progress needed for executive reviews
Support MS and Lupus strategic ops harmonization through standardized templates, reporting processes, and operating rhythms
Assist with MS meeting preparation (LT meetings, annual planning, etc.) as needed, ensuring consistency in quality and structure
Contribute to cross-portfolio planning activities and operational improvements across the Specialty franchises
Qualification
Required
7 years of experience in biotech/pharma, consulting, or relevant strategic operations roles
Strong planning, project management, and cross-functional coordination capabilities
Exceptional written communication skills, with ability to produce boardroom-ready materials (decision-oriented pre-reads, executive summaries, and complex cross-functional syntheses)
Negotiation and influence skills, with the ability to drive alignment among cross-functional stakeholders, manage competing priorities, and secure commitments without formal authority
Ability to synthesize complex inputs into clear, actionable storylines
Experience preparing materials for senior leadership forums
Strong analytical, problem-solving, and organizational skills
Bachelor's degree required
Preferred
MBA or advanced degree preferred
Experience in immunology or launch preparation a plus
Benefits
Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-05
Company data provided by crunchbase